Grant

Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)

CountryUnited States
DeadlineNot published
Published2026-09-23
SectorsHealth & life sciences
SourceGrants.gov (US)

Summary

Funding opportunity RFA-NS-28-009. CFDA: 93.853

The buyer, the value, the full description and the link to the official notice are available with a free account.